Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QD6T
|
|||
| Drug Name |
6,6-fused nitrogenous heterocyclic compound 2
|
|||
| Synonyms |
PMID25656651-Compound-32b
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H16FN3O
|
|||
| Canonical SMILES |
CC1=C(C=NC=C1C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4)F
|
|||
| InChI |
1S/C19H16FN3O/c1-11-16(9-21-10-17(11)20)14-5-4-13-7-18(22-8-15(13)6-14)23-19(24)12-2-3-12/h4-10,12H,2-3H2,1H3,(H,22,23,24)
|
|||
| InChIKey |
GSLMJIPSSNUWRV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.